A novel non-invasive mouse model of endometriosis for monitoring angiogenesis and the efficacy of anti-angiogenic therapy

A novel non-invasive mouse model of endometriosis for monitoring angiogenesis and the efficacy of anti-angiogenic therapy

Bibliographic Details
Main Authors:	Becker, C, Wright, R, Satchi-Fainaro, R, Funakoshi, T, Folkman, J, Kung, A, D'Amato, R
Format:	Conference item
Published:	2006

Similar Items

Angiogenesis and antiangiogenic therapy in endometriosis.
by: Becker, C, et al.
Published: (2007)

Circulating endothelial progenitor cells are up-regulated in a mouse model of endometriosis.
by: Becker, C, et al.
Published: (2011)

2-methoxyestradiol inhibits hypoxia-inducible factor-1{alpha} and suppresses growth of lesions in a mouse model of endometriosis.
by: Becker, C, et al.
Published: (2008)

Angiogenesis in endometriosis: the role of circulating angiogenic cells and the endometrium
by: Webster, K
Published: (2012)

Endometriosis and angiogenesis.
by: May, K, et al.
Published: (2008)

Levels of circulating angiogenic cells are not altered in women with endometriosis.
by: Webster, K, et al.
Published: (2013)

Vascular endothelial growth factor C is increased in endometrium and promotes endothelial functions, vascular permeability and angiogenesis and growth of endometriosis.
by: Xu, H, et al.
Published: (2013)

Vascular endothelial growth factor C is increased in endometrium and promotes endothelial functions, vascular permeability and angiogenesis and growth of endometriosis
by: Xu, H, et al.
Published: (2013)

Differential Suppression of Vascular Permeability and Corneal Angiogenesis by Nonsteroidal Anti-inflammatory Drugs
by: Pakneshan, P, et al.
Published: (2008)

A quantitative microfluidic angiogenesis screen for studying anti-angiogenic therapeutic drugs
by: Kim, Choong, et al.
Published: (2017)

Green tea epigallocatechin-3-gallate inhibits angiogenesis and suppresses vascular endothelial growth factor C/vascular endothelial growth factor receptor 2 expression and signaling in experimental endometriosis in vivo.
by: Xu, H, et al.
Published: (2011)

Vascular phenotype identification and anti-angiogenic treatment recommendation: A pseudo-multiscale mathematical model of angiogenesis
by: Hutchinson, LG, et al.
Published: (2016)

A novel noninvasive model of endometriosis for monitoring the efficacy of antiangiogenic therapy
by: Becker, C
Published: (2006)

Biomarkers of anti-angiogenic therapy in breast cancer
by: Mehta, S
Published: (2014)

Mathematical models of anti-angiogenic therapy and vessel normalisation
by: Hutchinson, L
Published: (2017)

Matrix metalloproteinases in patient urine as non-invasive surrogate markers for endometriosis.
by: Becker, C, et al.
Published: (2007)

Endometriosis
by: Zondervan, KT, et al.
Published: (2020)

Dynamics of vascular normalization during anti-angiogenic therapy : implications for combination therapy
by: Tong, Ricky T. (Ricky Tsee-Wai)
Published: (2008)

Enhancing the survival and angiogenic potential of mouse atrial mesenchymal cells
by: Malandraki-Miller, S, et al.
Published: (2016)

In Vitro and In Vivo Anti-Angiogenic Activities of Panduratin A
by: Lai, Siew Li, et al.
Published: (2012)

Endometriosis
by: Zondervan, KT, et al.
Published: (2018)

Endometriosis
by: Zondervan, KT, et al.
Published: (2018)

Galectin-3 acts as an angiogenic switch to induce tumor angiogenesis via Jagged-1/Notch activation.
by: Dos Santos, S, et al.
Published: (2017)

Investigating the relationship between BRAF status and melanoma response to anti-angiogenic therapy
by: Guo, L
Published: (2019)

Exosomes as biomarkers in endometriosis
by: Nazri, N, et al.
Published: (2018)

An insight into anti-angiogenic and anti-metastatic effects of oridonin: current knowledge and future potentials
by: Abdullah, Nurul Akmaryanti, et al.
Published: (2021)

Endometriosis: the authors reply
by: Becker, CM, et al.
Published: (2020)

Pharmacodynamic and pharmacokinetic markers for anti-angiogenic cancer therapy: Implications for dosing and selection of patients.
by: Morotti, M, et al.
Published: (2017)

Use of the mouse aortic ring assay to study angiogenesis.
by: Baker, M, et al.
Published: (2012)

Anti-Dll4 therapy: can we block tumour growth by increasing angiogenesis?
by: Sainson, R, et al.
Published: (2007)

Anti-angiogenesis in cancer therapeutics: the magic bullet
by: Oguntade, AS, et al.
Published: (2021)

Potential mechanisms of postmenopausal endometriosis.
by: Bendon, C, et al.
Published: (2012)

Potential mechanisms of postmenopausal endometriosis
by: Bendon, C, et al.
Published: (2012)

Anti-angiogenic effect of tamoxifen combined with epirubicin in breast cancer patients.
by: Mele, T, et al.
Published: (2010)

Anti-angiogenic effect of tamoxifen combined with epirubicin in breast cancer patients
by: Mele, T, et al.
Published: (2010)

Phyllanthusspp. Exerts Anti-Angiogenic and Anti-Metastatic Effects Through Inhibition on Matrix Metalloproteinase Enzymes
by: Tang, Yin-Quan, et al.
Published: (2015)

Nonsteroidal anti-inflammatory drugs for pain in women with endometriosis.
by: Allen, C, et al.
Published: (2009)

Nonsteroidal anti-inflammatory drugs for pain in women with endometriosis
by: Brown, J, et al.
Published: (2017)

Monitoring response to anti-angiogenic mTOR inhibitor therapy in vivo using (111)In-bevacizumab.
by: Patel, N, et al.
Published: (2017)

Functional and structural uncoupling of the angiogenic and enzymatic inhibitory activity of TIMPs : loop 6 of TIMP-2 is a novel inhibitor of angiogenesis
by: Fernández, Cecilia A., 1969-
Published: (2006)